Kuhli-Hattenbach, C; Miesbach, W; Scharrer, I et al.
Thrombophilic and systemic risk factors in patients with retinal vein occlusionOPHTHALMOLOGE. Bd. 108. H. 2. 2011 S. 104-110
Kreiter, S; Diken, M; Selmi, A et al.
Tumor vaccination using messenger RNA: prospects of a future therapyCURRENT OPINION IN IMMUNOLOGY. Bd. 23. H. 3. 2011 S. 399-406
Koslowski, M; Luxemburger, U; Tureci, O et al.
Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1 alphaONCOGENE. Bd. 30. H. 7. 2011 S. 876-882
Dreyling, M; Kluin-Nelemans, HC; Bea, S et al.
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma NetworkLEUKEMIA & LYMPHOMA. Bd. 52. H. 12. 2011 S. 2226-2236
Taube, C; Rydzy, L; Eich, A et al.
Use of a portable device to record maximum inspiratory flow in relation to dyspnoea in patients with COPDRESPIRATORY MEDICINE. Bd. 105. H. 2. 2011 S. 316-321
Stein, P; Rechtsteiner, G; Warger, T et al.
UV Exposure Boosts Transcutaneous Immunization and Improves Tumor Immunity: Cytotoxic T-Cell Priming through the SkinJOURNAL OF INVESTIGATIVE DERMATOLOGY. Bd. 131. H. 1. 2011 S. 211-219
Abegunewardene, N; Gori, T; Vosseler, M et al.
A 34-year-old man with cardiac arrhythmias and lymphadenopathyCLINICAL RESEARCH IN CARDIOLOGY. Bd. 99. H. 6. 2010 S. 401-403
Cornely, OA; Vehreschild, JJ; Ruping, MJGT et al.
A phase II dose escalation study of caspofungin for invasive aspergillosisMYCOSES. Bd. 53. H. 5. 2010 S. 376-377
Weidmann, E; Hess, G; Chow, KU et al.
A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomasLEUKEMIA & LYMPHOMA. Bd. 51. H. 3. 2010 S. 447-455
Wegner-Kops, J; Hemmerling, J; Wolff, D et al.
A xenograft model of human skin to study the role of antigen-presenting cells in inflammatory skin diseaseEXPERIMENTAL DERMATOLOGY. Bd. 19. H. 2. 2010 S. 185-185